NCT00002286View on ClinicalTrials.gov

A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV InfectionsPsoriasis
Interventions
DRUG

Zidovudine

Trial Locations (1)

27709

Glaxo Wellcome Inc, Research Triangle Park

Sponsors

Lead Sponsor

Glaxo Wellcome
All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY

NCT00002286 - A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients | Biotech Hunter | Biotech Hunter